# VL-3 Training Study

Study · id `cardio:ct-nct05356754` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05356754](<https://clinicaltrials.gov/study/NCT05356754>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05356754

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 343 participants.

## Technical summary

Registry record NCT05356754. Allocation not applicable; no masking; primary purpose other. Start 2020-07-13 (actual); primary completion 2021-11-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 343 participants (enrolled count; ClinicalTrials.gov record NCT05356754, source copy `cardio:ctgov-nct05356754-2022-05-02`, retrieved 2026-10-26)
- Started: 2020-07-13 (actual) (ClinicalTrials.gov record NCT05356754, source copy `cardio:ctgov-nct05356754-2022-05-02`, retrieved 2026-10-26)
- Primary completion: 2021-11-08 (actual) (ClinicalTrials.gov record NCT05356754, source copy `cardio:ctgov-nct05356754-2022-05-02`, retrieved 2026-10-26)
- Completion: 2021-11-08 (actual) (ClinicalTrials.gov record NCT05356754, source copy `cardio:ctgov-nct05356754-2022-05-02`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05356754, source copy `cardio:ctgov-nct05356754-2022-05-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05356754-2022-05-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: VL-3 Training Study
- Condition: Hypertension
- Condition: Blood Pressure
- Intervention (Device): The Vital Labs Digital Blood Pressure Monitor
- Lead sponsor: Riva Health
- Lead sponsor class: INDUSTRY
- Collaborator: Diablo Clinical Research
- Collaborator class: UNKNOWN
- Collaborator: University of Colorado, Denver
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as a collaborator: University of Colorado, Denver (`cardio:org-university-of-colorado-denver`)

## Provenance

Content hash: 753b7c35c7e4aae72d2a3c006669b5bfdab8769c074999066b0e94b2062ad58c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
